RECRUITING

Cardiology Biobank Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers. Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively. By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.

Official Title

Cardiology Biobank Registry

Quick Facts

Study Start:2003-12
Study Completion:2030-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00378924

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. All hospital and clinic patients aged 18 years and older
  2. 2. Patients with active cardiovascular disease including but not limited to
  3. 1. Ischemic Heart Disease
  4. 2. Heart Failure and Cardiomyopathies
  5. 3. Peripheral Vascular Disease
  6. 4. Valve disease
  7. 5. Adult Congenital Heart disease
  8. 6. Electrophysiological Disorders
  9. 3. Any Atlanta metropolitan area resident aged 18 and above in satisfactory physical health and able to tolerate a blood draw or buccal swab.
  1. 1. Significant Documented Anemia (Hemoglobin \<8 g/dL)
  2. 2. Blood transfusions within past 3 weeks
  3. 3. Active Cancer (non-skin cancers)
  4. 4. Enrollment against doctor recommendation
  5. 5. Patient not able to provide consent including but not limited to:
  6. 1. Intubated and critically unwell patients
  7. 2. Dementia
  8. 3. Alzheimer's disease
  9. 4. Moderate to severe alcohol or drug abuse
  10. 5. Against religious beliefs (e.g. Jehovah's witness

Contacts and Locations

Study Contact

Ayman J Tahhan, MD
CONTACT
404 712 0168
ayman.tahhan@emory.edu
Salman Sher, MD
CONTACT
404 412 0170
ssher2@emory.edu

Principal Investigator

Arshed A Quyyumi, MD
PRINCIPAL_INVESTIGATOR
Emory School Of Medicine

Study Locations (Sites)

Emory School Of Medicine
Atlanta, Georgia, 30322
United States

Collaborators and Investigators

Sponsor: Emory University

  • Arshed A Quyyumi, MD, PRINCIPAL_INVESTIGATOR, Emory School Of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2003-12
Study Completion Date2030-04

Study Record Updates

Study Start Date2003-12
Study Completion Date2030-04

Terms related to this study

Additional Relevant MeSH Terms

  • Cardiovascular Disease